Lexeo Therapeutics (LXEO) PT Lowered to $9 at Leerink Partners
Tweet
Share
E-mailGet Alerts LXEO Hot Sheet
Price: $4.99 -0.4%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar lowered the price target on Lexeo Therapeutics (NASDAQ: LXEO) to $9.00 (from $10.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
- Advent, Stripe Consortium Is Said To Drop Pursuit Of PayPal - Bloomberg
- Goldman Sachs on Marvell (MRVL): 'We expect the stock to be range bound following results that were in line'
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
